uniQure N.V. Files 8-K Report
Ticker: QURE · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financial-statements
TL;DR
uniQure filed an 8-K, mostly standard stuff, check exhibits for details.
AI Summary
On June 2, 2025, uniQure N.V. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or disclosures detailed in the provided text. It confirms the company's reporting status and basic identifying information.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming uniQure's compliance and providing access to its latest financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no new material events or financial disclosures mentioned in the provided text, indicating low immediate risk.
Key Players & Entities
- uniQure N.V. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- The Netherlands (location) — State or Other Jurisdiction of Incorporation
FAQ
What is the primary purpose of this 8-K filing by uniQure N.V.?
The filing is a Current Report on Form 8-K, primarily indicating the submission of financial statements and exhibits, as well as fulfilling Regulation FD disclosure requirements.
When was the earliest event reported in this filing?
The earliest event reported is dated June 2, 2025.
What is uniQure N.V.'s principal executive office address?
The address of uniQure N.V.'s Principal Executive Offices is Paasheuvelweg 25a, 1105 BP Amsterdam, The Netherlands.
What is uniQure N.V.'s telephone number?
uniQure N.V.'s telephone number, including area code, is +31 - 20-566-7394.
What is the Standard Industrial Classification (SIC) code for uniQure N.V.?
The Standard Industrial Classification code for uniQure N.V. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding uniQure N.V. (QURE).